Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75c5fdb46c70e2fe2987ec065954dc40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5da6937fad6afe670f59a47b9505b87c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2007-11-20^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c9e7ee8dd2554b219213c4bbdb862f1 |
publicationDate |
2008-06-12^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008069922-A1 |
titleOfInvention |
Compositions including triciribine and anthracyclin analogs and methods of use thereof |
abstract |
This application relates to combination therapies including triciribine and related compounds and anthracycline analogs and salts thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation. |
priorityDate |
2006-11-20^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |